Supreme Court Rejects Challenge to Abortion Drug Mifepristone

The Supreme Court unanimously rejected a challenge Thursday morning brought by a doctors’ group against the Food and Drug Administration’s (FDA) loosening of regulations of the abortion pill mifepristone, handing a win to the agency.

The court held that those challenging the status of the pill lacked legal standing to do so.

The decision came two years after the court’s landmark 2022 ruling in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade and returned the regulation of abortion to the states.

The 9–0 opinion was written by Justice Brett Kavanaugh. Justice Clarence Thomas filed a concurring opinion.
Medication abortions are reportedly lawful in 36 states and the District of Columbia.

Read Full Article Here
a building with a flag on top of it by Jimmy Woo is licensed under unsplash.com

Get latest news delivered daily!

We will send you breaking news right to your inbox